TORONTO, ON / ACCESSWIRE / September 21, 2023 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce the addition of Mr. Fabrice Pakin, Masters (Marketing & International Business), to the Board of Directors of AI/ML Innovations Inc.

Fabrice brings three decades of extensive IT knowledge and expertise to his new role, with an impressive 11-year track record as a trailblazer in the digital health sector. In 2021, Fabrice established Tech2Heal SAS, a company dedicated to driving the digital health revolution through the development of a code-free, interoperable, and rapidly deployable SaaS platform. Prior to that, in 2013, Fabrice spearheaded the creation of Ignilife, a pioneering SaaS platform for primary prevention in Europe. This groundbreaking platform, available in six languages and serving markets in France, Switzerland, Brazil, and Belgium, established strategic partnerships with prestigious insurance firms such as Malakoff Médéric, Groupe Mutuel in Switzerland, and Unimed in Brazil. Prior to these accomplishments, Fabrice held significant roles as a Business Unit Director/Manager within various technology companies.

Fabrice is stepping into the role previously held by Mr. Bruce Matichuk on the Company's Board of Directors. Mr. Matichuk will continue to be an invaluable member of the AI/ML Innovations team, remaining in the position of Chief Technology Officer for both AI/ML Innovations Inc. and Health Gauge Inc. The Company expresses its gratitude to Bruce for his service on the Board.

Additionally, the board of directors has approved the appointment of Tim Daniels, Executive Chairman of AI/ML Innovations Inc., to the additional position of Chief Financial Officer. Mr. Daniels has held the position of Interim Chief Financial Officer of the Company since April 28, 2023.

About AI/ML Innovations Inc. https://aiml-innovations.com/

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors
Tim Daniels, Executive Chairman

For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at www.sedar.com.
For further information, contact: Blake Fallis at (778) 405-0882 or This email address is being protected from spambots. You need JavaScript enabled to view it..

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For AI/ML Innovations Investors

Certain statements made in this press release that are not based on historical information are forward-looking statements that involve substantial known and unknown risks and uncertainties. This press release contains express or implied forward-looking statements relating to, among other things, AI/ML Innovations' expectations concerning management's plans, objectives and strategies, including strategies for defending the Company's intellectual property. These statements are neither promises nor guarantees but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. AI/ML Innovations Inc. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by AI/ML with the securities regulatory authorities, available at www.sedar.com.